Dr Robin Bradley Bauer, DO | |
1924 Alcoa Hwy # U-56, Knoxville, TN 37920-1511 | |
(865) 305-9081 | |
(865) 305-8769 |
Full Name | Dr Robin Bradley Bauer |
---|---|
Gender | Male |
Speciality | Hospitalist |
Experience | 16 Years |
Location | 1924 Alcoa Hwy # U-56, Knoxville, Tennessee |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1497901748 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | 2228 (Tennessee) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Of Tn Medical Center | Knoxville, TN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Health System, Inc. | 5294646378 | 526 |
News Archive
SemBioSys Genetics Inc., specializing in the manufacture of high-value proteins and oils in plant seeds, today announced preliminary results of its first "in-man" clinical study of SBS-1000, a recombinant human insulin manufactured using its proprietary platform.
Applied BioCode, Inc. announced that its BioCode-1000 Analyzer has been CE Certified under the compliance of Laboratory Equipment Standards EN55011, EN61010-1, EN61326-1, IEC61010, EN61000-3-2, and EN61000-3-3. The CE Certified marking that the BioCode-1000 Analyzer has met all relevant European Union consumer safety requirements.
Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, has purchased the cannulae product line from Estech.
Merrimack Pharmaceuticals, Inc. today announced that one cohort of a Phase 2 non-small cell lung cancer study did not meet its primary endpoint. The cohort evaluated MM-121 in combination with erlotinib to treat patients with NSCLC whose disease progressed on an anti-EGFR tyrosine kinase inhibitor (EGFR-TKI).
U.S. health regulators, the Food and Drugs Administration (FDA), have announced that ulcer drugs such as AstraZeneca Plc's blockbuster Nexium could increase the risk of Clostridium difficile-associated diarrhea (CDAD).
› Verified 3 days ago
Entity Name | University Health System, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1790738763 PECOS PAC ID: 5294646378 Enrollment ID: O20031111000809 |
News Archive
SemBioSys Genetics Inc., specializing in the manufacture of high-value proteins and oils in plant seeds, today announced preliminary results of its first "in-man" clinical study of SBS-1000, a recombinant human insulin manufactured using its proprietary platform.
Applied BioCode, Inc. announced that its BioCode-1000 Analyzer has been CE Certified under the compliance of Laboratory Equipment Standards EN55011, EN61010-1, EN61326-1, IEC61010, EN61000-3-2, and EN61000-3-3. The CE Certified marking that the BioCode-1000 Analyzer has met all relevant European Union consumer safety requirements.
Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, has purchased the cannulae product line from Estech.
Merrimack Pharmaceuticals, Inc. today announced that one cohort of a Phase 2 non-small cell lung cancer study did not meet its primary endpoint. The cohort evaluated MM-121 in combination with erlotinib to treat patients with NSCLC whose disease progressed on an anti-EGFR tyrosine kinase inhibitor (EGFR-TKI).
U.S. health regulators, the Food and Drugs Administration (FDA), have announced that ulcer drugs such as AstraZeneca Plc's blockbuster Nexium could increase the risk of Clostridium difficile-associated diarrhea (CDAD).
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Robin Bradley Bauer, DO 1924 Alcoa Hwy # U-114, Knoxville, TN 37920-1511 Ph: (865) 305-9340 | Dr Robin Bradley Bauer, DO 1924 Alcoa Hwy # U-56, Knoxville, TN 37920-1511 Ph: (865) 305-9081 |
News Archive
SemBioSys Genetics Inc., specializing in the manufacture of high-value proteins and oils in plant seeds, today announced preliminary results of its first "in-man" clinical study of SBS-1000, a recombinant human insulin manufactured using its proprietary platform.
Applied BioCode, Inc. announced that its BioCode-1000 Analyzer has been CE Certified under the compliance of Laboratory Equipment Standards EN55011, EN61010-1, EN61326-1, IEC61010, EN61000-3-2, and EN61000-3-3. The CE Certified marking that the BioCode-1000 Analyzer has met all relevant European Union consumer safety requirements.
Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, has purchased the cannulae product line from Estech.
Merrimack Pharmaceuticals, Inc. today announced that one cohort of a Phase 2 non-small cell lung cancer study did not meet its primary endpoint. The cohort evaluated MM-121 in combination with erlotinib to treat patients with NSCLC whose disease progressed on an anti-EGFR tyrosine kinase inhibitor (EGFR-TKI).
U.S. health regulators, the Food and Drugs Administration (FDA), have announced that ulcer drugs such as AstraZeneca Plc's blockbuster Nexium could increase the risk of Clostridium difficile-associated diarrhea (CDAD).
› Verified 3 days ago
Daniel Eugene Brewer, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1924 Alcoa Hwy, U56, Knoxville, TN 37920 Phone: 865-305-9081 Fax: 865-305-8769 | |
Dr. Ryan Douglas Kerr, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1924 Alcoa Hwy, U56, Knoxville, TN 37920 Phone: 865-305-9081 Fax: 865-305-8769 | |
Landy M Morales, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1924 Alcoa Hwy, Box 56, Knoxville, TN 37920 Phone: 865-305-9081 Fax: 865-305-8769 | |
Sahar M Lotfi, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1924 Alcoa Hwy, U56, Knoxville, TN 37920 Phone: 865-305-9081 Fax: 865-305-8769 | |
Dr. Clayton Devereau Humphrey, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1924 Alcoa Hwy # U56, Knoxville, TN 37920 Phone: 865-305-9081 Fax: 865-305-8769 | |
Dr. Christopher Hill, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1924 Alcoa Hwy # U56, Knoxville, TN 37920 Phone: 865-305-9081 Fax: 865-305-8769 | |
Murad Salaita, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1924 Alcoa Hwy, U56, Knoxville, TN 37920 Phone: 865-305-9081 Fax: 865-305-8769 |